Leading health agency says no to HRT

A leading US health agency is standing firm on its recommendation against the use of hormone replacement therapy (HRT) in postmenopausal women.

In a review of its 2012 recommendations, the US Preventive Services Task Force (USPSTF) has again concluded that the evidence does not support a role for HRT for preventing fractures and other chronic conditions.

While oral or transdermal HRT may have a place for managing vasomotor symptoms, the agency says it has “no net benefit” for the primary